Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer.

J Breast Cancer · 2017 · PMC5378580 · PMID 28382095

Europe PMC DOI

hedged sentence

0.0460

closest p · 0.9× alpha

0.0460

boldest claim

The sentences

marginally significantp =0.046actually significant

Results Regarding NCCN classification, BCL2 was a strong favorable prognostic factor in the HR(+)/HER2(–) subtype ( p <0.001) and a marginally significant favorable prognosticator in the HR(+)/HER2(+) subtype ( p =0.046).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.